Baird Financial Group
ESPR

Baird Financial Group’s Esperion Therapeutics ESPR Stock Holding History

Baird Financial Group’s Portfolio ESPR Stock Details ESPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-21,254
Closed -$1.09M – 1513
2020
Q2 		$1.09M Buy
+21,254
New +$889K ﹤0.01% 901
2020
Q1 		– Sell
-18,829
Closed -$1.12M – 1461
2019
Q4 		$1.12M Buy
18,829
+305
+2% +$13.7K ﹤0.01% 933
2019
Q3 		$679K Buy
18,524
+849
+5% +$33.6K ﹤0.01% 1082
2019
Q2 		$823K Buy
+17,675
New +$830K ﹤0.01% 1055
2016
Q2 		– Sell
-10,240
Closed -$173K – 1211
2016
Q1 		$173K Buy
+10,240
New +$165K ﹤0.01% 1167

Other funds holding ESPR

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
MG
Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return